The single gene of CD200, CHI3L2, CNTN1, CTSL, FYB1, and SLC52A1 and the combination model have been confirmed to have an association with the prognosis of advanced NSCLC patients, and the stability and independence have been verified. The gene discussed is CD200; the disease is non-small cell lung carcinoma.